iPremom Pregnancy Healthcare Diagnostics
PrivateLast Round
Seed
Sep 2, 2026
Total Funding Raised
$17.4M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
iPremom Pregnancy Healthcare Diagnostics is a biotechnology company that develops molecular diagnostic tests for the early detection and prevention of pregnancy complications such as preeclampsia.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Patient Engagement, E-commerce
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iPremom Pregnancy Healthcare Diagnostics Comparables
Compare iPremom Pregnancy Healthcare Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gravidas Diagnostics Inc. | 56% | |
| Kalia Health, Inc. | 53% | |
| NextGen Jane | 49% |
iPremom Pregnancy Healthcare Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 2, 2026 | ||||
| Grant | Feb 19, 2026 |
iPremom Pregnancy Healthcare Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Seed |
| Amadeus Capital Partners | Seed |
| European Innovation Council Fund | Grant |
| APEX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
$17M round led by Amadeus Capital Partners.
iPremom Pregnancy Healthcare Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access